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ABSTRACT
Objective: To determine the accessibility and currency
of delirium guidelines, guideline summary papers and
evaluation studies, and critically appraise guideline quality.
Design: 1. Systematic literature search for formal
guidelines (in English or French) with focus on
delirium assessment and/or management in adults
(≥18 years), guideline summary papers and evaluation
studies. 2. Full appraisal of delirium guidelines
published between 2008 and 2013 and obtaining a
‘Rigour of Development’ domain screening score cut-
off of >40% using the Appraisal of Guidelines for
Research and Evaluation (AGREE II) instrument.
Data sources: Multiple bibliographic databases,
guideline organisation databases, complemented by
a grey literature search.
Results: 3327 database citations and 83 grey
literature links were identified. A total of 118 retrieved
delirium guidelines and related documents underwent
full-text screening. A final 21 delirium guidelines (with
10 being >5 years old), 12 guideline summary papers
and 3 evaluation studies were included. For 11 delirium
guidelines published between 2008 and 2013, the
screening AGREE II ‘Rigour’ scores ranged from 3% to
91%, with seven meeting the cut-off score of >40%.
Overall, the highest rating AGREE II domains were
‘Scope and Purpose’ (mean 80.1%, range 64–100%)
and ‘Clarity and Presentation’ (mean 76.7%, range 38–
97%). The lowest rating domains were ‘Applicability’
(mean 48.7%, range 8–81%) and ‘Editorial
Independence’ (mean 53%, range 2–90%). The three
highest rating guidelines in the ‘Applicability’ domain
incorporated monitoring criteria or audit and costing
templates, and/or implementation strategies.
Conclusions: Delirium guidelines are best sourced by
a systematic grey literature search. Delirium guideline
quality varied across all six AGREE II domains,
demonstrating the importance of using a formal
appraisal tool prior to guideline adaptation and
implementation into clinical settings. Adding more
knowledge translation resources to guidelines may
improve their practical application and effective
monitoring. More delirium guideline evaluation studies
are needed to determine their effect on clinical practice.
INTRODUCTION
Delirium is a common neurocognitive dis-
order with the hallmark of disturbed
attention and awareness developing over a
short period of time.1 Common predisposing
risk factors for delirium are advanced age
and dementia. Delirium prevalence in
general medical hospital settings is 18–
35%,2 3 26–62% in palliative care units,4 and
30–70% in critical care, depending on the
patient population and assessment
methods.5 6 Prevalence rates of up to 88% at
the end of life (last hours to weeks of life)
have been reported.4 7 However, the diagno-
sis of delirium is frequently missed or mis-
diagnosed in multiple clinical settings due to
ﬂuctuating symptoms and signs, in addition
to a lack of routine cognitive screening and
assessment of attention.2 8–12 Delirium causes
functional impairment, increased falls,
increased healthcare costs, prolonged hospi-
talisation with an increased risk of placement
in long-term care at discharge and increased
risk of mortality.13 14 It worsens pre-existing
dementia and increases the risk for develop-
ing de novo dementia.15 Delirium also causes
signiﬁcant psychological distress for patients,
families and healthcare providers.16 It has
been estimated that ∼30% of delirium epi-
sodes can be prevented and treated using
multicomponent non-pharmacological strat-
egies.2 17 Delirium is usually multifactorial in
Strengths and limitations of this study
▪ A strength of this study is the usage of an
experienced university health sciences librarian
to assist with the search strategy for the system-
atic literature search.
▪ A complement of four (rather than two) apprai-
sers conducted the full Appraisal of Guidelines
for Research and Evaluation (AGREE II) quality
assessment of the delirium guidelines.
▪ It was not possible to retrieve the full text for all
literature search citations.
▪ Language was restricted to English and French
for the second-level screening.
▪ Two delirium guideline updates have been pub-
lished since the initial literature search.
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origin, and is potentially reversible if the identiﬁed pre-
cipitant/s are treatable. Although the current mainstay
of delirium treatment is supportive non-pharmacological
care, pharmacological treatment of delirium with anti-
psychotics has historically been used despite limited evi-
dence for efﬁcacy and concerns regarding their adverse
effects, especially in patients with pre-existing demen-
tia.18–23 It should also be noted that currently no anti-
psychotic has an ofﬁcial indication for delirium. Various
pharmacological agents have also been trialled as delir-
ium preventative strategies.2 24 The multidimensional
management of delirium requires interprofessional com-
prehensive care. With signiﬁcant ongoing patient mor-
bidity and healthcare costs due to delirium, there
remains a pressing need to improve the overall manage-
ment of this deleterious clinical syndrome for patients
and their families.
Shaneyfelt stated that clinical practice guidelines
should enhance healthcare quality and outcomes for
many conditions.25 Guidelines may potentially assist clini-
cians with clinical care and decision-making, and provide
standardisation of care delivery across disciplines within
an institution as well as interinstitutional benchmarking.
Clinical practice guidelines have been deﬁned as ‘system-
atically developed statements to assist practitioner and
patient decisions about appropriate healthcare for spe-
ciﬁc clinical circumstances’.26 More recently, the
Canadian Medical Association handbook on clinical prac-
tice guidelines stated that guidelines aim to ‘summarise
research ﬁndings and make clinical decisions more trans-
parent’ and ‘identify gaps in knowledge and prioritise
research activities’.27 Recently, authors have questioned
the trustworthiness of guidelines.25 28 Only applicable,
high-quality, rigorous, non-biased guidelines with valid
recommendations should be selected by clinicians to
adapt and implement into their clinical practice.29–31
Multiple clinical practice guidelines on delirium have
been published despite a lack of high-level evidence for
the management of delirium, with the result that many
ﬁnal guideline recommendations are derived from
‘expert’ opinion.32 Our previous non-systematic search
for formal delirium guidelines demonstrated that guide-
lines were difﬁcult to source using selected databases.32
We subsequently sought to determine and review rigor-
ous national and international delirium guidelines that
would be applicable for adaptation and implementation
into a palliative care setting, as well as develop a site-
speciﬁc evaluation strategy. To the best of our knowl-
edge, the quality and validity of published delirium
guidelines have not been reported. To appraise their
currency and accessibility, we conducted a systematic
search for delirium guidelines published between 1990
and 2013. Using the Appraisal of Guidelines for
Research and Evaluation (AGREE II) instrument,33 a
critical assessment of the quality and validity of guide-
lines published from 2008 to 2013 was performed. In
addition, guideline summaries and studies evaluating
implemented guidelines were identiﬁed.
METHODS
Data sources and searches
A systematic literature search for existing delirium clin-
ical practice guidelines for any clinical setting, summary
papers and studies evaluating implemented guidelines
was conducted in multiple electronic bibliographic data-
bases by an information specialist librarian. The search
for the Cochrane Library and the Database of Reviews of
Effects (DARE), Medline (Ovid), EMBASE (Ovid),
CINAHL, PsycINFO (Ovid) and TRIP (Turning Research
into Practice) databases was executed on 16 August 2013
with no date limitations, and no language or age restric-
tion. Search terms included ‘delirium’, ‘guideline’,
‘health planning guideline’, and ‘Clinical protocols’.
Box 1 shows the search strategy for Medline (Ovid).
For this project, we used the CAN-IMPLEMENT
Resource, a detailed guideline adaptation and imple-
mentation planning resource that was developed by the
Canadian Guideline Adaptation Study Group. As per
CAN-IMPLEMENT recommendations,34 a search of
guideline organisation databases, including the USA
National Guideline Clearinghouse (NGC)35 and the
Guidelines International Network (G-I-N) International
Guideline Library,36 was also performed. Using the
aforementioned search terms, a grey literature search
was performed (between 9 May and 20 December 2013)
through Google and Google Scholar, as well as reviewing
the websites of relevant organisations, such as inter-
national delirium associations. Any possible documents
related to delirium guidelines (such as summary versions
and pathways) found on the grey literature search were
retrieved. Supplemental hand searching for delirium
guidelines was also conducted.
Appraisal of Guidelines for Research and Evaluation II
instrument (AGREE II)
The AGREE II instrument appraises the quality of guide-
lines by focusing on the guideline development process,
as opposed to formally evaluating the content of a
guideline. It consists of 23 items in six distinct domains:
‘Scope and Purpose’, ‘Stakeholder Involvement’,
‘Rigour of Development’, ‘Clarity and Presentation’,
‘Applicability’ and ‘Editorial Independence’. Each
AGREE II item is scored on a 7-point scale from 1=
strongly disagree to 7= strongly agree. An additional two
global rating items at the end of AGREE II provide an
overall assessment of the guideline. Domain 3 of AGREE
II, the ‘Rigour of Development’ domain, has eight items
and assesses the ‘process of gathering and summarising
the evidence, and methods used to develop recommen-
dations’.33 Within the ‘Rigour of Development’ domain,
AGREE II item number 10 considers that ‘the health
beneﬁts, side effects and risks have been considered in
formulating the recommendations’. The 4-item Domain
5, known as ‘Applicability’, ‘pertains to the likely barriers
and facilitators to implementation, strategies to improve
uptake and resource implications of applying the guide-
line’.33 The online version of the AGREE II instrument
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was used to appraise the quality of guidelines after all
appraisers had completed standardised online training.33
Delirium clinical practice guideline selection
The retrieved citations and internet sources were initially
independently screened by two appraisers (SB, KM)
according to title and abstract. Inclusion criteria
included: full and short versions of formal clinical prac-
tice guidelines, as deﬁned by Field and Lohr (see
above),26 with a focus on the topic of delirium and in
any clinical setting for adults ≥18 years, guideline
summary papers and studies evaluating guidelines.
Citations were excluded if the scope of the paper was on
alcohol withdrawal delirium (delirium tremens), paedi-
atric population only or literature reviews on delirium
management (systematic or otherwise). Duplicates were
included at this stage to identify individual citation
numbers per database.
Citations meeting the above inclusion criteria went
through a second-level screening of full-text articles and
internet sources (SB, KM) to determine the delirium
clinical practice guidelines to be assessed, with incongru-
ities regarding a citation’s eligibility being resolved by
consensus. Guidelines to be assessed were deﬁned as
formal delirium guidelines, or clinical practice guide-
lines, with a focus on delirium assessment and/or man-
agement in an adult population (≥18 years) in either
English or French language, ‘produced by a sanctioned
legitimate group’ (ie, a formal endorsed guideline devel-
opment committee or task force, as opposed to an indi-
vidual contributor) with a systematic literature search
and including clear evidence-informed recommenda-
tions linked to deﬁned levels of evidence,34 and pub-
lished within one of the following three time periods:
2008–2013, 2003–2007, older than 2003. Guidelines that
solely focused on the management of postoperative
delirium were excluded as the authors’ aim was to
review guidelines that were most applicable to patients
in a medical inpatient or palliative care setting. Delirium
guidelines published between the years 2008 and 2013
were determined to be ‘high priority’ guidelines due to
currency, thereby matching the NGC inclusion criteria
that require its included guidelines to have been ‘devel-
oped, reviewed or revised within the previous ﬁve
years’.35
Two appraisers (SB, KM) independently assessed delir-
ium guidelines published between 2008 and 2013 using
the ‘Rigour’ domain of the AGREE II instrument, as
recommended by CAN-IMPLEMENT V.3.1.34 37
Differences were resolved by consensus. To include a
local provincial delirium guideline, guidelines meeting
an AGREE II ‘Rigour of Development’ domain cut-off of
>40% were submitted to the next step in quality
assessment.
Quality assessment of delirium guidelines
Four members of the research team (SB/KM/MA/DD)
independently appraised the ﬁnal included guidelines
using the full 23-item AGREE II instrument, followed by
a teleconference consensus discussion among all four
appraisers. Standardised domain scores for each of the
six AGREE II domains were calculated as recommended
by AGREE II. In addition, the appraisers added contem-
poraneous ﬁeld notes and completed the two global
Box 1 Methodology for systematic appraisal of delirium
clinical practice guidelines
Medline (Ovid) search strategy:
1. Delirium/
2. deliri*.tw.
3. (acute adj1 confusion).tw.
4. (acute adj1 brain adj1 syndrome).tw.
5. (metabolic adj1 encephalopath*).tw.
6. (acute adj1 organic adj1 psychosyndrome).tw.
7. (acute adj1 psycho-organic adj1 syndrome).tw.
8. (clouded adj1 state).tw.
9. (clouding adj3 consciousness).tw.
10. (exogenous adj1 psychos*).tw.
11. (toxic adj1 confusion).tw.
12. (toxic adj1 psychos*).tw.
13. Confusion/
14. (acute adj1 confusional adj1 state).tw.
15. (acute adj1 brain adj1 failure).tw.
16. (terminal* adj1 restless*).tw.
17. (terminal adj1 agitation).tw.
18. (psychomotor adj1 agitation).tw.
19. (cognitive adj1 failure).tw.
20. disorientation.tw.
21. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12
or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20
22. exp guideline/
23. exp Guidelines as Topic/
24. guideline*.pt.
25. practice guideline.pt.
26. Health Planning Guidelines/
27. Clinical Protocols/
28. Critical Pathways/
29. (practice adj3 paramet*).tw.
30. (clinical adj3 pathway*).tw.
31. consensus development conference.pt.
32. consensus development conference nih.pt.
33. 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31
or 32
34. 21 and 33
Guideline databases:
National Guideline Clearinghouse (http://www.guideline.gov),
Guidelines International Network (http://www.g-i-n.net), National
Institute for Clinical Excellence (http://www.nice.org.uk)
Scottish Intercollegiate Guidelines Network (http://www.sign.ac.
uk), New Zealand Guidelines Group (http://www.nzgg.org.nz)
Canadian Medical Association—CMA Infobase: Clinical Practice
Guidelines (http://www.cma.ca/cpgs/)
Other databases:
CareSearch (http://www.caresearch.com.au/Caresearch/Default.aspx),
Centre for Effective Practice (http://www.effectivepractice.org)
Delirium associations:
European Delirium Association (http://www.europeandeliriumas
sociation.com), American Delirium Society (http://www.
americandeliriumsociety.org)
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rating items at the end of each AGREE II assessment.
The ﬁrst global rating item asks appraisers to rate the
overall quality of the guideline on a 7-point scale (1=
lowest possible quality and 7= highest possible quality).
The second global rating item asks whether the
appraiser would recommend the guideline for use in
practice, with options of ‘yes’, ‘yes, with modiﬁcations’,
and ‘no’.
RESULTS
Systematic search for delirium clinical practice guidelines
The systematic search generated 3327 citations, of which
1629 were for the search strategy time period 2008–
2013. Ninety-three database citations related to guide-
lines met the inclusion criteria (see ﬁgure 1).
Second-level screening of full-text articles assessed some
articles with the word ‘guideline’ in the title as literature
reviews or protocols for delirium management without
clear links between level of evidence and
recommendations; these were excluded. The grey litera-
ture search of websites resulted in 21 additional docu-
ments related to ‘guidelines’. The search of the global
G-I-N Library using the term ‘delirium’ found 77 results
out of 6444 entries. Seven entries appeared to meet the
inclusion criteria of which only one had been retrieved
from the above search.38 It was not possible to retrieve
the other six possible guidelines (all non-English: four
written in Dutch, one in French and one in German) as
no research team member had G-I-N membership.39–44
With the addition of four delirium guidelines found on
hand searching, a total of 118 retrieved guidelines and
documents related to guidelines underwent full-text
screening for eligibility.
Twenty-one stand-alone delirium guidelines were iden-
tiﬁed from the second-level screening; 11 published
between 2008 and 2013, 7 between 2003 and 2007, and
3 guidelines published before 2003 (see tables 1 and 2).
The initial ‘Rigour of Development’ domain scores for
the 11 guidelines ≤5 years old from the two appraisers
Figure 1 Flow diagram of delirium guideline selection procedure.
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ranged from 3% to 91% (see table 1). To include a local
provincial delirium guideline,49 a ‘Rigour’ domain
cut-off score of >40% was used, resulting in a ﬁnal seven
‘high priority’ guidelines requiring further evaluation,
and four excluded guidelines.51–54
The ﬁnal seven ‘high priority’ guidelines from 2008
to 2013 were all written in English, with four having
been developed in Canada, two in the USA and one
in the UK. Both guidelines from the Registered Nurses
Association of Ontario (RNAO) were originally pub-
lished in 2003: we evaluated the revised 2010 supple-
ments. The 2009 full version of the guideline by
Sendelbach et al (updated from 1998) was purchased
from the University of Iowa after sourcing it via a
website link on the Medline-retrieved summary guide-
line paper. The target users were healthcare providers
for three guidelines,38 47 50 healthcare providers pro-
viding care to patients with cancer-related symptom
management throughout the disease trajectory for one
guideline,49 nurses (Registered Nurses and Registered
Practical Nurses) for two guidelines46 48 and intensive
care unit (ICU) clinicians for one guideline.45 Four
guidelines were limited to older adults,46–48 50
although only two provided an age deﬁnition for
‘older adult’. The 2010 Clinical Guideline 103
(CG103) on delirium (with an ‘Evidence Update’ in
April 2012 which was also reviewed by the appraisers)
from the National Clinical Guideline Centre (NCGC)
was commissioned by the National Institute for Health
and Clinical Excellence (NICE).38 It was the longest
guideline, comprising 447 pages in its full version in
addition to 10 appendices, implementation tools and
care pathway.
The NICE guideline speciﬁcally excluded ‘people
receiving end-of-life care’. The guideline by the
Canadian Coalition for Seniors’ Mental Health
(CCSMH) was developed speciﬁcally for palliative care
patients and deﬁned ‘approaching the end of life’ as ‘to
living currently with a terminal illness and having an
estimated life expectancy of six months or less’.47 The
ICU guideline (for the management of pain, agitation
and delirium or ‘PAD’) was published by Barr et al45 as
a special article in a specialist journal, rather than as a
stand-alone guideline. This meant that while it was
easily sourced on searching electronic databases, such
as Medline, CINAHL and EMBASE, the initial version
of the guideline had to be cut by 10–20% due to
journal space restrictions.65 Three guidelines searched
for pre-existing guidelines from which to make their
recommendations, as opposed to being de novo
guidelines.46 48 49
Quality appraisal of selected guidelines (published
between 2008 and 2013) using the AGREE II instrument
Table 3 summarises the AGREE II domain scores and
overall results of the quality assessment.
The seven selected ‘high priority’ delirium guidelines
scored highest for the ‘Scope and Purpose’ domain
(mean 80.1%, range 64–100%); and the ‘Clarity and
Presentation’ domain (mean 76.7%, range 38–97%).
Overall the lowest rating domains were Domain 5,
‘Applicability’ (mean 48.7%, range 8–81%), and
Domain 6, ‘Editorial Independence’, (mean 53%, range
2–90%). The mean values for the remaining two
domains were 62.3% (‘Rigour of Development’) and
58.6% (‘Stakeholder Involvement’). The 2010 NCGC/
NICE guideline was the highest rated guideline in ﬁve of
the six domains (range 81–100%). Only the ‘PAD’ ICU
guideline, which was rated the highest for ‘Editorial
Independence’, was recommended for use without mod-
iﬁcations by all four appraisers.
The RNAO guidelines received the highest ratings for
monitoring criteria (presented in the original 2003 and
2004 guidelines) and provided a link for a separate com-
prehensive Toolkit (available in English and French) for
implementing guidelines.66 The RNAO screening guide-
line had been pilot tested at three teaching hospitals,
resulting in a summary of implementation strategies
within the guideline. The NICE guideline had a costing
report and costing template available, in addition to a
brief implementation advice document and audit tem-
plate. From the contemporaneous ﬁeld notes, it was
noted that the ‘PAD’ ICU guideline did not rely on
expert opinion and explicitly made no recommendation
if insufﬁcient evidence or no group consensus reached.
Two appraisers thought that the length of the full NICE
guideline may impede implementation, but noted that
the guideline had excellent summary documents includ-
ing a 29-page shorter version and a 10-page ‘Quick refer-
ence guide’. One appraiser found it challenging to
navigate through PDF versions of several guidelines
without running titles to deﬁne sections.
Systematic search for guideline summaries, dissemination
papers and studies
For the years 2008–2013, four of the ﬁnal seven
appraised guidelines had published dissemination
papers, with the NICE guideline having two summary
publications17 67 (see table 4). All the dissemination
papers were sourced through Medline.
Three dissemination papers were published in 2003–
2007,73–75 and two before 2003.76 77 Six of the 11
retrieved guidelines (2008–2013) had guideline summar-
ies published on the NGC website35 (see table 5).
From the literature search, only three studies (all cited
in EMBASE) described the evaluation of implemented
delirium guidelines. Mudge et al78 reported an
Australian controlled trial of implementation of a 2006
guideline on the management of delirium in older
people on a medical ward compared with a control
ward.56 Twenty-two per cent of the patients were deliri-
ous on admission and no incident cases of delirium
were identiﬁed. In the delirious subgroup, there was a
trend to a lower use of antipsychotic medications (26%
vs 41%, p=0.46). In the intervention group there was a
longer duration of admission, a trend to reduced
Bush SH, et al. BMJ Open 2017;7:e013809. doi:10.1136/bmjopen-2016-013809 5
Open Access
Table 1 AGREE II initial ‘rigour’ domain scores for delirium clinical practice guidelines (published 2008–2013)
Clinical practice guideline name
Guideline development
group
Year of
publication
Country/
language Database source
Target patient
population
Initial Rigour
domain
score
Delirium: diagnosis, prevention National Clinical Guideline
Centre (NCGC):
Commissioned by National
Institute for Health and Care
Excellence (NICE)
2010 England: English Grey literature,
TRIP; Guideline
summary (NGC):
TRIP
Adult patients ≥18 years
in a hospital setting and
long-term residential care
91%
and management. Clinical Guideline
103 (CG103)38
Clinical practice guidelines for the
management of pain, agitation and
delirium in adult patients in the
intensive care unit45
The American College of 2013 USA: English Medline,
EMBASE,
CINAHL;
Guideline
summary (NGC):
TRIP
Intubated and
non-intubated adult
medical, surgical and
trauma intensive care
unit patients
58%
Critical Care Medicine task
force
Caregiving strategies for older adults
with delirium, dementia and
depression46
Registered Nurses Association
of Ontario (RNAO)
2010 update
(Original:
2004)
Canada: English Grey literature,
TRIP; Guideline
summary (NGC):
TRIP
Older adults ≥65 years
with delirium, dementia
and/or depression
55%
Guideline on the assessment and
treatment of delirium in older adults at
the end of life47
Canadian Coalition for
Seniors’ Mental Health
(CCSMH)
2010 Canada: English Grey literature Older adults ≥65 years
with or at risk of
developing delirium and
approaching the end of
life
54%
Screening for delirium, dementia and
depression in older adults48
Registered Nurses Association
of Ontario (RNAO)
2010 update
(Original:
2003)
Canada: English Grey literature,
TRIP; Guideline
summary (NGC):
TRIP
Older adult clients 48%
Cancer Care Ontario’s Symptom
management guide-to-practice:
Delirium49
Cancer Care Ontario (CCO) 2010 Canada: English Grey literature Adult patients who
require symptom
management related to
cancer
43%
Acute Confusion/Delirium50 Sendelbach S, Finch Guthrie
P. (University of Iowa College
of Nursing)
2009 USA: English Hand search;
Guideline
summary (NGC):
TRIP
Elderly hospitalised
patients (general
medical/surgical units)
42%
Evidence and consensus-based
German guidelines for the
management of analgesia, sedation
and delirium in intensive care51
Association of Scientific
Medical Societies (AWMF) of
Germany
2010 Germany:
English (Original
version)/German
Medline Critically ill patients 21%
Continued
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inpatient mortality, and signiﬁcantly fewer patients were
discharged with persistent delirium (32% vs 71%,
p=0.016). The authors commented that implementation
was costly, aside from the cost due to increased length of
acute ward stay. Voellinger et al79 described the effect of
guideline implementation in a general hospital in
Switzerland on nurses’ and physicians’ knowledge after a
1-hour education session using pre-MCQ and post-MCQ
questionnaires. The study illustrated the effort required
for implementation but no assessment was made of clin-
ical outcomes. In 2003, Young and George reported a
pre-evaluation and postevaluation of the implementation
using cluster randomisation of a British Geriatrics
Society delirium guideline implemented in ﬁve hospitals
with graduated ‘intensity’.80 One hospital received the
‘low-intensity’ intervention: this consisted of feedback of
baseline data alone from an earlier study. From chart
review of patients with a diagnosis of delirium, the base-
line data included frequency of mental test score admin-
istration, alcohol history, use of non-pharmacological
management strategies and sedation, in addition to com-
plications and length of stay. Two hospitals received the
addition of guideline distribution to nurses and doctors
(‘medium-intensity’ intervention); two hospitals received
additional teaching sessions (‘high-intensity’ interven-
tion). There was an improvement in process and
outcome of care in the high-intervention group only,
but this was not statistically signiﬁcant. The authors con-
cluded that guidelines themselves did not improve delir-
ium management.
DISCUSSION
This study describes the systematic search process and
quality appraisal of published delirium clinical guide-
lines across clinical settings. The key ﬁndings from the
literature search were the importance of the grey litera-
ture search strategy to source delirium guidelines, as
opposed to sourcing guideline summary papers and
evaluation studies in indexed databases, and the lack of
currency for many guidelines. Of note, nine of the 11
guidelines published between 2008 and 2013 were
found solely through the grey literature search. This is
in keeping with our previous experience of sourcing
delirium guidelines, where a lower proportion of guide-
lines were retrieved from biomedical electronic data-
bases.32 Similarly in a search for dementia guidelines,
Azermai et al81 retrieved over half of the appraised
guidelines from the web. For our study, the NGC website
was an effective way to identify and source recently pub-
lished guidelines.35 82 Only the CCSMH guideline for
older adults with delirium at the end of life did not have
an NGC guideline summary.47 However, the six delirium
guidelines with NGC summaries varied with their ﬁnal
AGREE II ‘Rigour of Development’ domain ratings, with
two rating below 40% in this domain.50 54 In contrast to
sourcing delirium guidelines, bibliographic databases
appear to be the best source for guideline summary
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Table 2 Summary of delirium clinical practice guidelines published (1) between 2003 and 2007 (2) before 2003
Delirium guideline name Guideline development Group Year Country Language
Database
source Target patient population
Delirium: Guidelines for general
hospitals55
The Delirium Guidelines
Development Group
‘A multidisciplinary expert panel’
2007 Switzerland English Medline,
EMBASE,
PsycINFO
Adult patients in general hospitals
Clinical practice guidelines for the
management of delirium in older
people56
Clinical Epidemiology and Health
Service Evaluation Unit, Melbourne
Health in collaboration with the
Delirium Clinical Guidelines Expert
Working Group
2006 Australia English Grey literature Older people receiving care (in hospital,
community and residential care
settings) aged ≥65 years, or ≥45 years
in the case of Aboriginal and Torres
Strait Islander people
National guidelines for seniors’
mental health: The assessment
and treatment of delirium57
Canadian Coalition for Seniors’
Mental Health (CCSMH)
2006 Canada English/
French
Grey literature Older adults ≥65 years, all healthcare
settings
Symptom Guidelines: Delirium/
Restlessness58
Hospice Palliative Care Clinical
Practice Guideline Committee, Fraser
Health
2006 Canada English Grey literature Adult patients ≥19 years living with
advanced life-threatening illness
Guidelines for the prevention,
diagnosis and management of
delirium in older people. Concise
guidance to good practice series,
No 659
Guideline Development Group: British
Geriatrics Society and Royal College
of Physicians
2006 UK English Hand search Older people in hospital and community
care settings
Detection, prevention and
treatment of delirium in critically ill
patients60
UK Clinical Pharmacy Association 2006 UK English Hand search Critically ill patients
(Guideline: Delirium)61 Dutch Psychiatric Association. van
der Mast RC et al
2005 Netherlands Dutch Medline,
EMBASE
Not known due to language restriction
Clinical practice guidelines for the
sustained use of sedatives and
analgesics in the critically ill
adult62
Sedation and Analgesia Taskforce,
Society of Critical Care Medicine and
American Society of Health-System
Pharmacists
2002 USA English EMBASE Critically ill adults
Clinical practice guideline:
Delirium in the elderly63
Fraser Health Authority 2002 Canada English Grey literature Elderly patients with delirium
Practice guideline for the
treatment of patients with
delirium64
American Psychiatric Association 1999 USA English Medline,
EMBASE,
PsycINFO, Grey
literature
Patients with delirium
8
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Table 3 Final AGREE II domain scores and global ratings
Delirium guideline name
Domain 1:
Scope and
Purpose
Domain 2:
Stakeholder
Involvement
Domain 3:
Rigour of
Development
Domain 4:
Clarity of
Presentation
Domain 5:
Applicability
Domain 6:
Editorial
Independence
Overall
global rating
scale
(average)
Overall
recommendation
(to use guideline)
Delirium: diagnosis, prevention
and management (NICE Clinical
Guideline 103 (CG103))38
100% 85% 93% 97% 81% 85% 6.75 Yes (3 reviewers)
Yes with modifications
(1 reviewer)
Clinical practice guidelines for the
management of pain, agitation
and delirium in adult patients in
the intensive care unit45
96% 56% 78% 93% 60% 90% 6.25 Yes (4 reviewers)
Caregiving strategies for older
adults with delirium, dementia and
depression46
86% 58% 65% 85% 69% 46% 6.75 Yes (2 reviewers)
Yes with modifications
(2 reviewers)
Guideline on the assessment and
treatment of delirium in older
adults at the end of life47
76% 65% 58% 74% 8% 44% 4.5 Yes (1 reviewer)
Yes with modifications
(3 reviewers)
Screening for delirium, dementia
and depression in older adults48
71% 60% 61% 79% 72% 48% 5 Yes (3 reviewers)
Yes with modifications
(1 reviewer)
Cancer Care Ontario’s Symptom
management guide-to-practice:
Delirium49
68% 58% 47% 71% 16% 56% 3.75 Yes (1 reviewer)
Yes with modifications
(3 reviewers)
Acute Confusion/Delirium50 64% 28% 34% 38% 35% 2% 3.5 No (2 reviewers)
Yes with modifications
(2 reviewers)
Mean 80.1% 58.6% 62.3% 76.7% 48.7% 53.0%
Range 64–100% 28–85% 34–93% 38–97% 8–81% 2–90%
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papers as part of a guideline dissemination strategy. In
this study, all the summary papers of delirium guidelines
published between 2008 and 2013 were cited in the
Medline database, as well as some of the other com-
monly used electronic databases. It was disappointing to
ﬁnd little evidence for further knowledge translation
with only three publications from 2003 to 2013 describ-
ing the formal evaluation of fully implemented delirium
guidelines (as opposed to published reports of the
implementation process and facilitators and barriers to
guideline implementation) being retrieved. Almost 50%
of the delirium guidelines were >5 years old, yet the
median lifespan of NICE guidelines is 60 months.83 It is
important for guidelines to maintain currency and
remain relevant and valid with mechanisms designed to
incorporate important new research ﬁndings efﬁciently.
A ‘red ﬂag monitoring system’ has been proposed to
allow timely incorporation of exceptional updates with
the collation of alerts and medical product safety
information from national authorities, for example, US
Food and Drug Administration (FDA), Health
Canada, European Medicines Agency.84 Partial updating
of guidelines from systematic monitoring may be more
practical, cost-effective and provide more timely recom-
mendations than using scheduled full updates (usually
every 3–5 years).
A key ﬁnding of the quality appraisal was the variation
in quality of formal delirium clinical guidelines across all
six AGREE II domains and lack of practical implementa-
tion and audit tools for many guidelines. Performing an
initial AGREE II assessment with two appraisers evaluat-
ing the ‘Rigour’ dimension was a practical way to reduce
the number of delirium guidelines requiring full
AGREE II appraisal. The 2010 NICE delirium guideline
received the highest AGREE II overall quality rating and
domain scores for all domains, except ‘Editorial
Independence’.38 Considering all seven delirium guide-
lines (published between 2008 and 2013) selected for
the full AGREE II appraisal, the ‘Applicability’ and
‘Editorial Independence’ domains were frequently the
lowest rated. This result is similar to ﬁndings by other
authors appraising guidelines with the original AGREE
Table 4 Retrieved dissemination summary papers for delirium guidelines (2008–2013)
Summary paper title Author(s)
Year of
publication
Database source
(eg, Medline,
Google)
Guidelines referred to; year of
guideline publication
Clinical practice guidelines for the
management of pain, agitation and
delirium in adult patients in the
intensive care unit: Executive
summary68
Barr et al 2013 Medline, CINAHL,
EMBASE
Clinical practice guidelines for the
management of pain, agitation and
delirium in adult patients in the
intensive care unit; 201345
Developing guidelines on the
assessment and treatment of
delirium in older adults at the end
of life69
Brajtman et al 2011 Medline Guideline on the assessment and
treatment of delirium in older adults
at the end of life; 201047
Das Delir—Konsequenzen für die
Analgosedierung kritisch kranker
Patienten (ICU delirium:
Consequences for management of
analgesia and sedation in the
critically ill)70
Lütz and
Spies
(In German)
2011 Medline,
EMBASE
Analgesie, Sedierung und
Delirmanagement in der
Intensivmedizin. S3-LL (DGAI/DIVI)
(Evidence and consensus-based
German guidelines for the
management of analgesia, sedation
and delirium in intensive care)—
AWMF (DED)—Association of
Scientific Medical Societies; 2009
(valid until 01.12.2014) (G-I-N
Library; not accessible)
Synopsis of the National Institute
for Health and Clinical Excellence
guideline for prevention of
delirium67
O’Mahony
et al
2011 Medline, CINAHL,
EMBASE
Delirium: diagnosis, prevention and
management. NICE Clinical
Guideline 103; 201038
Diagnosis, prevention, and
management of delirium: summary
of NICE guidance17
Young et al 2010 Medline,
EMBASE
Delirium: diagnosis, prevention and
management. NICE Clinical
Guideline 103; 201038
Evidence-based guideline: Acute
confusion/delirium71
Sendelbach
et al
2009 Medline Acute Confusion/Delirium; 200950
Clinical practice guidelines for the
management of delirium in older
people in Australia72
Tropea et al 2008 Medline, CINAHL,
PsycINFO
Clinical practice guidelines for the
management of delirium in older
people; 200656
NICE, National Institute for Health and Care Excellence.
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instrument or updated AGREE II version.81 85–87 As the
four items for the AGREE II ‘Applicability’ domain
(facilitators and barriers to guideline application, provi-
sion of implementation tools and/or advice on how to
put recommendations into practice, consideration of
resource implications, and provision of monitoring and/
or audit criteria) help healthcare providers operational-
ise a guideline into clinical practice as well as monitor
its effectiveness, a low-rating ‘Applicability’ domain may
lead to challenges with sustainability of the guideline
once implemented. As part of the AGREE II ‘Editorial
Independence’ domain, it is vital that members of a
guideline development committee have declared any
potential conﬂicts of interest, especially ﬁnancial, or
links with industry, and that this information is clearly
accessible within the guideline itself or as an appendix,
to ensure that the reader is well informed and can assess
for potential bias.29
A strength of this study is the usage of an experienced
university health sciences librarian to assist with the
development of the search strategy for the systematic lit-
erature search. Adding to the methodological rigour
and reliability of the AGREE II assessment, a comple-
ment of four (rather than two) appraisers conducted
the full AGREE II quality assessment of the delirium
guidelines. This is in keeping with the recommendations
of the AGREE II user’s manual.33 Although the apprai-
sers were inexperienced in guideline evaluation, all had
completed the AGREE II online training module. All
appraisers had clinical and research interests in delirium
in palliative care or older populations. A limitation is
that it was not possible to retrieve the full text for all the
citations from the literature search or from the G-I-N
International Guideline Library, in addition to the lan-
guage restriction to English and French for the
second-level screening. While it is necessary to be a sub-
scribed G-I-N member to retrieve guidelines from the
G-I-N website, it is possible to search the International
Guideline Library for identiﬁcation of guidelines and
whether the guideline status is ‘in development’, ‘pub-
lished’ or ‘under review’.36 For this study, the full
AGREE appraisal focused on ‘recent’ delirium guide-
lines that had been published within the previous
5 years at the time of the literature search. The literature
continues to evolve with the subsequent development or
revision of guidelines, which were not included as part
of this study. The CCSMH has published a 2014 update
(in English and French) for its 2006 guideline on ‘The
assessment and treatment of delirium’ in seniors.88
From the G-I-N website,36 the Dutch College of General
Practitioners published Delier (M77) (Delirium) on 1
April 2014. This appears to be an update of a 2003
(M77) guideline. From the NICE website, the next
review date for the NICE CG103 guideline is 2018, as
there was found to be no requirement to update this
guideline at the last review in January 2015.38
This study conﬁrms the importance of systematic grey
literature searches to source tangible delirium clinical
practice guidelines, and to ensure important guidelines
are not overlooked. Poor accessibility of a guideline
reduces compliance, in addition to its complexity and
length.89 This study also illustrates the importance of
using a formal appraisal tool, such as a full AGREE II
assessment, to ensure that only high-quality delirium
guidelines are adapted by clinicians for use in practice.
Strengthening of items derived from the AGREE II
Table 5 National Guideline Clearinghouse (NGC) published summaries for delirium guidelines (2008–2013)
NGC guideline
summary name Guideline developer Year
Delirium clinical practice guidelines
referred to Country
Guideline
summary
NGC-9692
Society of Critical Care
Medicine
2013 (revision of
1995 version)
Clinical practice guidelines for the
management of pain, agitation and delirium
in adult patients in the intensive care unit45
USA
Guideline
summary
NGC-9461
Family Practice Oncology
Network; Medical Services
Commission
2011 British Columbia guidelines: Palliative care
for the patient with incurable cancer or
advanced disease. Part 2: Pain and
symptom management54
Canada
Guideline
summary
NGC-8072
National Clinical Guideline
Centre for Acute and
Chronic Conditions
2010 Delirium: diagnosis, prevention and
management. NICE Clinical Guideline 10338
UK
Guideline
summary
NGC-8381
Registered Nurses’
Association of Ontario
2004 (addendum
released May
2010)
Caregiving strategies for older adults with
delirium, dementia and depression46
Canada
Guideline
summary
NGC-8380
Registered Nurses’
Association of Ontario
2003 (addendum
released May
2010)
Screening for delirium, dementia and
depression in older adults48
Canada
Guideline
summary
NGC-7208
University of Iowa College
of Nursing
2009 (revision of
1998 version)
Acute Confusion/Delirium50 USA
NICE, National Institute for Health and Care Excellence.
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‘Applicability’ domain would improve many of the delir-
ium guidelines that we reviewed. By providing a robust
‘Applicability domain’, guideline developers can assist
busy healthcare providers at the bedside with speciﬁc
audit recommendations and provision of user-friendly
templates for comparative audits preguideline and post-
guideline implementation, in addition to practical
implementation tools. We envision that by using the
recently published AGREE Reporting Checklist (avail-
able on the AGREE Enterprise website as a free and
open access resource (http://www.agreetrust.org)),
guideline development groups will improve the compre-
hensiveness and completeness of new guidelines across
all AGREE II domains.90 The AGREE II instrument was
developed from the original AGREE version.91 92 While
to the authors’ knowledge, the AGREE II has not been
subsequently revalidated, AGREE II is widely accepted
and has been used extensively to appraise guidelines.93
The AGREE II does not formally evaluate the content of
a guideline, including guideline criteria for evidence or
the validity of guideline recommendations. Indeed it has
been shown that the methodological quality of guide-
lines should not infer content validity.94
We found limited evidence of evaluation studies of
delirium guidelines (with or without local adaptation) in
their implemented settings. In addition to assessing the
impact of guidelines on the quality of care, other identi-
ﬁed desired outcomes, and assessment of guideline sus-
tainability and cost-effectiveness, there should also be
assessments for unintended consequences or undesir-
able outcomes to ensure that patient health and family
outcomes are improved. A limitation to this study in
assessing impact of guidelines is that it only included sci-
entiﬁc literature and guidelines that had been published
or retrieved by the grey literature search. The extensive
quality assessment and improvement initiatives that are
in place in individual institutions and networks across
the world and their impact on care were not examined.
Considering that the development and implementation
of formal guidelines can be challenging, taking time,
money and resources at the local level, a possible prac-
tical starting point to improve care is to encourage
uptake and benchmarking of quality improvement mea-
sures related to delirium. NICE quality standards are
concise and measurable enabling the development of
local quality measures.95 For example, the NICE Quality
Standard 63 for delirium management recommends ﬁve
key standards.96
Future research needs to ensure that clinical practice
guidelines are of high quality, user-friendly, relevant and
non-biased as only ‘rigorous’ guidelines should be
adapted into formats suitable for use in daily clinical
practice. Crucial outstanding factors to enable guidelines
to change practice are effective interprofessional imple-
mentation strategies at the local level to optimise
uptake, maximum accessibility of guideline key points
with practical and simple interprofessional clinical
prompts and algorithms available at the point of care,
and ensuring ongoing sustainability with long-term
organisational support. A challenge for delirium guide-
lines in general remains the need for more primary
research evidence (and higher quality studies) to inform
them.
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